Practice Management News

The FDA granted emergency use authorization for the monoclonal antibodies casirivimab and imdevimab to be administered together intravenously for the treatment of mild to moderate COVID-19.

In this exclusive video, Andrew Allegretti, MD, MSc, from Massachusetts General Hospital, discusses his poster from The Liver Meeting Digital Experience on hepatorenal syndrome and acute kidney injury in patients with liver disease.

Opioid use among older Medicare beneficiaries dropped during a recent 4-year period, but a “substantial” number of these individuals were considered chronic and heavy opioid users, researchers wrote.

An artificial intelligence voice analysis tool can help diagnose COVID-19 in asymptomatic patients, according to its manufacturer, Vocalis Health.

Physicians may find some relief from administrative burdens by utilizing community health workers during the COVID-19 pandemic, a speaker at the virtual North Carolina Department of Health and Human Services' Rural Primary Care Conference said.

Performing sequential non-invasive tests more accurately measured severity of fatty liver than single tests or simultaneous tests, according to a researcher at The Liver Meeting Digital Experience.

Speaking at The Liver Meeting Digital Experience, Anthony S. Fauci, MD, restated actions needed to control the current resurgence of COVID-19, recommended treatments and his “cautious optimism” about recently released vaccine study data.

Despite guidelines to ensure proper screening, one study presented during the Liver Meeting Digital Experience showed only 42% of infants born to women with hepatitis C and cirrhosis are screened and followed for hepatitis C.

As we navigate through this difficult time in the U.S. economy, a few bright spots emerge. One of those is the fact that interest rates, controlled by the Federal Reserve, are at all-time lows.

Phase 3 clinical trial results indicate that Russia’s Sputnik V vaccine was 92% effective against COVID-19, according to a press release from the Russian Direct Investment Fund, or RDIF.